Accelerated Testing of New Biomarkers

The Swedish company Biovica has developed a blood test (DiviTum™) that provides accurate measures of cell-division rates in blood. Testing and validation was accelerated by ready access to blood samples from Karolinska University Hospital’s biobank. These had been collected during a clinical study including 287 women with breast cancer undergoing two different kinds of chemotherapy. 

Thomas Hatschek, Associate Professor at Karolinska Institutet and lead investigator for the study performed at Karolinska University Hospital